Mr. Clint Sharples reports

HERITAGE CANNABIS HOLDINGS SUBSIDIARY CANNACURE RECEIVES SALES LICENSE FROM HEALTH CANADA

Health Canada has granted a cannabis oil sales licence to Heritage Cannabis Holdings Corp.'s subsidiary CannaCure Corp., effective Oct. 9, 2020. This sales licence will allow CannaCure to begin selling cannabis products, including oil derivatives, directly to the provincial cannabis boards.

Heritage already offers several products through their subsidiary Voyage Cannabis Corp., including Pura Vida CBD 4:1 honey oil, and indica, sativa and hybrid-honey-oil vape cartridges, as well as Purefarma moon, sun and earth vape cartridges. Tinctures include Pura Vida "Daybreak" and "Nightfall" full-spectrum THC tinctures and the popular Purefarma Hemplixer full-spectrum CBD tinctures in two concentrations, HLX15 and HLX30.

None of the products manufactured and sold by Heritage subsidiaries CannaCure and Voyage contain any potentially harmful additives or have terpenes added back in.

"Having the CannaCure sales licence granted by Health Canada is another accomplishment for the Heritage team and follows on recent positive news of our acquisition of Opticann Inc., and the availability of our products through the medical site patient choice," stated Clint Sharples, chief executive officer of Heritage. "We are on a strong trajectory in the Canadian and U.S. cannabis markets and having our sales licence at CannaCure provides the optionality and flexibility for the business as we continue on our successful path."

About Heritage Cannabis Holdings Corp.

Heritage Cannabis is a vertically integrated cannabis provider that currently has two Health-Canada-approved licensed producers through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp. both regulated under the Cannabis Act Regulations. Working under these two licences, Heritage has two additional subsidiaries: Purefarma Solutions, which provides extraction services; and a medical Services division which is focused on cannabis-based medical solutions. In the United States, Heritage operates under Opticann Inc., a Colorado-based oral-and-topical-cannabinoid company with the rights to exclusively sell CBD and CBG products made with the patented VESIsorb drug delivery system for optimized absorption and stability. As the parent company, Heritage is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.